665 related articles for article (PubMed ID: 32825423)
1. P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases.
Illes P
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32825423
[TBL] [Abstract][Full Text] [Related]
2. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor: an emerging target in central nervous system diseases.
Sperlágh B; Illes P
Trends Pharmacol Sci; 2014 Oct; 35(10):537-47. PubMed ID: 25223574
[TBL] [Abstract][Full Text] [Related]
4. Ion channels on microglia: therapeutic targets for neuroprotection.
Skaper SD
CNS Neurol Disord Drug Targets; 2011 Feb; 10(1):44-56. PubMed ID: 21143139
[TBL] [Abstract][Full Text] [Related]
5. A Possible Causal Involvement of Neuroinflammatory, Purinergic P2X7 Receptors in Psychiatric Disorders.
Zhang Y; Yin HY; Rubini P; Tang Y; Illes P
Curr Neuropharmacol; 2022; 20(11):2142-2155. PubMed ID: 35236262
[TBL] [Abstract][Full Text] [Related]
6. Astrocytic and Oligodendrocytic P2X7 Receptors Determine Neuronal Functions in the CNS.
Zhao YF; Tang Y; Illes P
Front Mol Neurosci; 2021; 14():641570. PubMed ID: 33642994
[TBL] [Abstract][Full Text] [Related]
7. Role and therapeutic targets of P2X7 receptors in neurodegenerative diseases.
Zheng H; Liu Q; Zhou S; Luo H; Zhang W
Front Immunol; 2024; 15():1345625. PubMed ID: 38370420
[TBL] [Abstract][Full Text] [Related]
8. The neuroinflammatory astrocytic P2X7 receptor: Alzheimer's disease, ischemic brain injury, and epileptic state.
Ahn YH; Tang Y; Illes P
Expert Opin Ther Targets; 2023; 27(9):763-778. PubMed ID: 37712394
[TBL] [Abstract][Full Text] [Related]
9. The purinergic P2X7 receptor as a potential drug target to combat neuroinflammation in neurodegenerative diseases.
Calzaferri F; Ruiz-Ruiz C; de Diego AMG; de Pascual R; Méndez-López I; Cano-Abad MF; Maneu V; de Los Ríos C; Gandía L; García AG
Med Res Rev; 2020 Nov; 40(6):2427-2465. PubMed ID: 32677086
[TBL] [Abstract][Full Text] [Related]
10. The role of glutamate release mediated by extrasynaptic P2X7 receptors in animal models of neuropathic pain.
Andó RD; Sperlágh B
Brain Res Bull; 2013 Apr; 93():80-5. PubMed ID: 23047057
[TBL] [Abstract][Full Text] [Related]
11. Involvement of P2X7 receptors in chronic pain disorders.
Ren WJ; Illes P
Purinergic Signal; 2022 Mar; 18(1):83-92. PubMed ID: 34799827
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
13. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
14. Interactions of pannexin 1 with NMDA and P2X7 receptors in central nervous system pathologies: Possible role on chronic pain.
Bravo D; Maturana CJ; Pelissier T; Hernández A; Constandil L
Pharmacol Res; 2015 Nov; 101():86-93. PubMed ID: 26211949
[TBL] [Abstract][Full Text] [Related]
15. Ethanol differentially modulates P2X4 and P2X7 receptor activity and function in BV2 microglial cells.
Asatryan L; Ostrovskaya O; Lieu D; Davies DL
Neuropharmacology; 2018 Jan; 128():11-21. PubMed ID: 28943285
[TBL] [Abstract][Full Text] [Related]
16. Nucleotide signaling in astrogliosis.
Franke H; Illes P
Neurosci Lett; 2014 Apr; 565():14-22. PubMed ID: 24103370
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of P2X7 receptors in CNS health and disease.
Tewari M; Seth P
Ageing Res Rev; 2015 Nov; 24(Pt B):328-42. PubMed ID: 26478005
[TBL] [Abstract][Full Text] [Related]
18. The microglial ATP-gated ion channel P2X7 as a CNS drug target.
Bhattacharya A; Biber K
Glia; 2016 Oct; 64(10):1772-87. PubMed ID: 27219534
[TBL] [Abstract][Full Text] [Related]
19. The NADPH oxidase pathway is dysregulated by the P2X7 receptor in the SOD1-G93A microglia model of amyotrophic lateral sclerosis.
Apolloni S; Parisi C; Pesaresi MG; Rossi S; Carrì MT; Cozzolino M; Volonté C; D'Ambrosi N
J Immunol; 2013 May; 190(10):5187-95. PubMed ID: 23589615
[TBL] [Abstract][Full Text] [Related]
20. A current review on P2X7 receptor antagonist patents in the treatment of neuroinflammatory disorders: a patent review on antagonists.
Soni S; Lukhey MS; Thawkar BS; Chintamaneni M; Kaur G; Joshi H; Ramniwas S; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):4643-4656. PubMed ID: 38349395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
